These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 25649244)

  • 1. Adherence to prophylaxis and quality of life in children and adolescents with severe haemophilia A.
    García-Dasí M; Aznar JA; Jiménez-Yuste V; Altisent C; Bonanad S; Mingot E; Lucía F; Giménez F; López MF; Marco P; Pérez R; Fernández MÁ; Paloma MJ; Galmes B; Herrero S; García-Talavera JA
    Haemophilia; 2015 Jul; 21(4):458-64. PubMed ID: 25649244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Describing the quality of life of boys with haemophilia in China: Results of a multicentre study using the CHO-KLAT.
    Tang L; Xu W; Li CG; Hou F; Feng XQ; Wang H; Li XJ; Li WL; Liu JP; Sun LR; Wang SH; Jin J; Fang Q; Luke KH; Poon MC; Blanchette VS; Usuba K; Young NL; Wu R
    Haemophilia; 2018 Jan; 24(1):113-119. PubMed ID: 28922525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment patterns, health-related quality of life and adherence to prophylaxis among haemophilia A patients in the United States.
    Duncan N; Shapiro A; Ye X; Epstein J; Luo MP
    Haemophilia; 2012 Sep; 18(5):760-5. PubMed ID: 22548353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient powered prophylaxis: A 12-month study of individualized prophylaxis in adults with severe haemophilia A.
    Sun HL; McIntosh KA; Squire SJ; Yang M; Bartholomew C; Gue DS; Camp PG; Jackson SC
    Haemophilia; 2017 Nov; 23(6):877-883. PubMed ID: 28851133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current prescription of prophylactic factor infusions and perceived adherence for children and adolescents with haemophilia: a survey of haemophilia healthcare professionals in the United States.
    Thornburg CD; Carpenter S; Zappa S; Munn J; Leissinger C
    Haemophilia; 2012 Jul; 18(4):568-74. PubMed ID: 22335526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health-related quality of life and health status in adolescent and adult people with haemophilia A without factor VIII inhibitors-A non-interventional study.
    Oldenburg J; Tran H; Peyvandi F; Núñez R; Trask P; Chebon S; Mahlangu JN; Lehle M; Jiménez-Yuste V; von Mackensen S
    Haemophilia; 2021 May; 27(3):398-407. PubMed ID: 33576546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of the impact of treatment on quality of life of patients with haemophilia A at different ages: insights from two clinical trials on turoctocog alfa.
    Santagostino E; Lentz SR; Busk AK; Regnault A; Iorio A
    Haemophilia; 2014 Jul; 20(4):527-34. PubMed ID: 24471912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-standing prophylactic therapy vs. episodic treatment in young people with severe haemophilia: a comparison of age-matched Danish and Russian patients.
    Ingerslev J; Lethagen S; Hvitfeldt Poulsen L; Sørensen B; Lopatina E; Tentsova I; Yastrubinetskaya O; Plyushch OP
    Haemophilia; 2014 Jan; 20(1):58-64. PubMed ID: 24354479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylaxis with anti-inhibitor coagulant complex improves health-related quality of life in haemophilia patients with inhibitors: results from FEIBA NF Prophylaxis Study.
    Stasyshyn O; Antunes S; Mamonov V; Ye X; Epstein J; Xiong Y; Tangada S
    Haemophilia; 2014 Sep; 20(5):644-50. PubMed ID: 24589084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemophilia-Specific Quality of Life Index (Haemo-QoL and Haem-A-QoL questionnaires) of children and adults: result of a single center from Turkey.
    Mercan A; Sarper N; Inanir M; Mercan HI; Zengin E; Kiliç SÇ; Gökalp AS
    Pediatr Hematol Oncol; 2010 Sep; 27(6):449-61. PubMed ID: 20615067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adherence to treatment in a Western European paediatric population with haemophilia: reliability and validity of the VERITAS-Pro scale.
    Lock J; Raat H; Duncan N; Shapiro A; Beijlevelt M; Peters M; Tamminga RY; Leebeek FW; Moll HA; Cnossen MH
    Haemophilia; 2014 Sep; 20(5):616-23. PubMed ID: 24861732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adherence to Prophylaxis in Adolescents and Young Adults with Severe Haemophilia: A Quantitative Study with Patients.
    van Os SB; Troop NA; Sullivan KR; Hart DP
    PLoS One; 2017; 12(1):e0169880. PubMed ID: 28103266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of severe haemophilia A on patients' health status: results from the guardian(™) 1 clinical trial of turoctocog alfa (NovoEight(®) ).
    Ozelo M; Chowdary P; Regnault A; Busk AK
    Haemophilia; 2015 Jul; 21(4):451-7. PubMed ID: 25677761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Objective quantification of adherence to prophylaxis in haemophilia patients aged 12 to 25years and its potential association with bleeding episodes.
    Pérez-Robles T; Romero-Garrido JA; Rodriguez-Merchan EC; Herrero-Ambrosio A
    Thromb Res; 2016 Jul; 143():22-7. PubMed ID: 27172834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Long-term health-related quality of life and related factors in children with severe hemophilia A who received regular low-dose prophylaxiss].
    Li Z; Zhou Y; Zhang SN; Li KX; Zhao YQ; Wang SJ; Xiao J
    Zhonghua Yi Xue Za Zhi; 2024 Jul; 104(29):2745-2750. PubMed ID: 39075994
    [No Abstract]   [Full Text] [Related]  

  • 16. [Quality of life of young patients with haemophilia in Europe].
    Bullinger M; Gringeri A; von Mackensen S
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Jun; 51(6):637-45. PubMed ID: 18481032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pilot study of once-a-day prophylaxis for youth and young adults with severe haemophilia A.
    Crivianu-Gaita V; Rivard GE; Carcao M; Teitel J; St-Louis J; Blanchette V; Pullenayegum E; Abad A; Feldman BM
    Haemophilia; 2016 Sep; 22(5):e401-5. PubMed ID: 27481574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimization of home treatment in haemophilia: effects of transmural support by a haemophilia nurse on adherence and quality of life.
    Lock J; Raat H; Peters M; Scholten M; Beijlevelt M; Oostenbrink R; Leebeek FW; Moll HA; Cnossen MH
    Haemophilia; 2016 Nov; 22(6):841-851. PubMed ID: 27778434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of traditional vs. Canadian tailored prophylaxis dosing of prophylactic factor infusions in children with haemophilia A and B in a single hemophilia treatment center.
    Dodd C; Watts RG
    Haemophilia; 2012 Jul; 18(4):561-7. PubMed ID: 22221939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Consequences of switching from prophylactic treatment to on-demand treatment in late teens and early adults with severe haemophilia A: the TEEN/TWEN study.
    Manco-Johnson MJ; Sanders J; Ewing N; Rodriguez N; Tarantino M; Humphries T;
    Haemophilia; 2013 Sep; 19(5):727-35. PubMed ID: 23750875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.